Thermodynamic Stability Analysis of Tolbutamide Polymorphs and Solubility in Organic Solvents
2016 (English)In: Journal of Pharmaceutical Sciences, ISSN 0022-3549, E-ISSN 1520-6017, Vol. 105, no 6, 1901-1906 p.Article in journal (Refereed) Published
Melting temperatures and enthalpies of fusion have been determined by differential scanning calorimetry (DSC) for 2 polymorphs of the drug tolbutamide: FIH and FV. Heat capacities have been determined by temperature-modulated DSC for 4 polymorphs: FIL, FIH, FII, FV, and for the supercooled melt. The enthalpy of fusion of FII at its melting point has been estimated from the enthalpy of transition of FII into FIH through a thermodynamic cycle. Calorimetric data have been used to derive a quantitative polymorphic stability relationship between these 4 polymorphs, showing that FII is the stable polymorph below approximately 333 K, above which temperature FIH is the stable form up to its melting point. The relative stability of FV is well below the other polymorphs. The previously reported kinetic reversibility of the transformation between FIL and FIH has been verified using in situ Raman spectroscopy. The solid-liquid solubility of FII has been gravimetrically determined in 5 pure organic solvents ( methanol, 1-propanol, ethyl acetate, acetonitrile, and toluene) over the temperature range 278 to 323 K. The ideal solubility has been estimated from calorimetric data, and solution activity coefficients at saturation in the 5 solvents determined. All solutions show positive deviation from Raoult's law, and all van't Hoff plots of solubility data are nonlinear. The solubility in toluene is well below that observed in the other investigated solvents. Solubility data have been correlated and extrapolated to the melting point using a semiempirical regression model.
Place, publisher, year, edition, pages
Elsevier, 2016. Vol. 105, no 6, 1901-1906 p.
polymorph, solubility, thermodynamics, FTIR, Raman spectroscopy, crystal polymorphism, calorimetry (DSC), activity coefficient, transformation
Pharmacology and Toxicology
IdentifiersURN: urn:nbn:se:kth:diva-192413DOI: 10.1016/j.xphs.2016.03.021ISI: 000381770100015PubMedID: 27238487ScopusID: 2-s2.0-84969921272OAI: oai:DiVA.org:kth-192413DiVA: diva2:968757
FunderSwedish Research Council, 621-2010-5391
QC 201609122016-09-122016-09-122016-09-12Bibliographically approved